Related Experiment Video
Updated: Aug 1, 2026
07:48
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
22.9K
Streamlining workflow and automation to accelerate laboratory scale protein production
Jennifer Konczal1, Christopher H Gray1
1Drug Discovery Program, CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, United Kingdom.
Protein Expression and Purification
|March 24, 2017
Summary
This review explores methods to accelerate recombinant protein production in Escherichia coli. It highlights innovative molecular biology, screening, and automated chromatography techniques to improve efficiency for demanding research applications.
Area of Science:
- Biochemistry and Molecular Biology
- Protein Science
- Biotechnology
Background:
- Protein production facilities face bottlenecks in supplying diverse proteins for techniques like crystallography and NMR.
- High demand for recombinant proteins necessitates increased capacity and throughput in production pipelines.
- Advancements in protein engineering and production are crucial for ambitious scientific projects.
Purpose of the Study:
- To review current and emerging strategies for accelerating recombinant protein production in Escherichia coli.
- To highlight technologies implemented in the laboratory for enhancing protein production efficiency.
- To provide insights into optimizing the protein production pipeline.
Main Methods:
- Innovative molecular biology techniques and expression vectors.
- Small-scale expression screening strategies for rapid assessment.
- Automation of parallel and multidimensional chromatography for purification.
Main Results:
- Implementation of novel methods has shown potential to increase protein production capacity.
- Evaluated technologies offer accelerated timelines for generating recombinant proteins.
- Optimized screening and purification processes improve overall throughput.
Conclusions:
- Accelerated protein production in E. coli is achievable through integrated technological advancements.
- Innovative molecular biology, screening, and automated chromatography are key to overcoming production bottlenecks.
- These strategies enhance the efficiency and success rate of protein production for research.
Related Concept Videos
01:14Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:29Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...